| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 92, 51-56, Copyright © 1987 by American College of Chest Physicians
ARTICLES |
MW Peterson, M Monick and GW Hunninghake
Idiopathic pulmonary fibrosis (IPF) and pulmonary fibrosis associated with a collagen vascular disorder (PF-CVD) are chronic inflammatory lung disorders which may be characterized in various subgroups of patients by increased numbers of macrophages, neutrophils, lymphocytes, and/or eosinophils. Previous studies have suggested that the cell populations recovered with bronchoalveolar lavage (BAL) may be important in predicting disease progression and response to therapy. We evaluated this hypothesis in 27 patients by determining if the cell populations recovered with BAL differed between patients who improved, remained stable, or worsened in their pulmonary functions (as defined by at least a 15 percent change in forced vital capacity) over a six- month observation period. The findings suggested that BAL eosinophilia may be a marker of progressive lung disease in patients with IPF and PF- CVD.
This article has been cited by other articles:
|
|
 |
|
  N. Enomoto, T. Suda, M. Kato, Y. Kaida, Y. Nakamura, S. Imokawa, M. Ida, and K. Chida Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest, July 1, 2006; 130(1): 22 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Huaux, M. Gharaee-Kermani, T. Liu, V. Morel, B. McGarry, M. Ullenbruch, S. L. Kunkel, J. Wang, Z. Xing, and S. H. Phan Role of Eotaxin-1 (CCL11) and CC Chemokine Receptor 3 (CCR3) in Bleomycin-Induced Lung Injury and Fibrosis Am. J. Pathol., December 1, 2005; 167(6): 1485 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Asakura, Y. Kashio, K. Nakamura, M. Seki, S. Dai, Y. Shirato, M. J. Abedin, N. Yoshida, N. Nishi, T. Imaizumi, et al. Selective Eosinophil Adhesion to Fibroblast Via IFN-{gamma}-Induced Galectin-9 J. Immunol., November 15, 2002; 169(10): 5912 - 5918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghosh, T. Mendoza, L. A. Ortiz, G. W. Hoyle, C. D. Fermin, A. R. Brody, M. Friedman, and G. F. Morris Bleomycin Sensitivity of Mice Expressing Dominant-Negative p53 in the Lung Epithelium Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 890 - 897. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Selman, T. E. King Jr., and A. Pardo Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Ann Intern Med, January 16, 2001; 134(2): 136 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Tsukamoto, H Hayakawa, A Sato, K Chida, H Nakamura, and K Miura Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis Thorax, November 1, 2000; 55(11): 958 - 961. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Hao, D. A. Cohen, C. D. Jennings, J. S. Bryson, and A. M. Kaplan Bleomycin-induced pulmonary fibrosis is independent of eosinophils J. Leukoc. Biol., October 1, 2000; 68(4): 515 - 521. [Abstract] [Full Text]
|
|
|
|
|
|
T. King Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 646 - 664. [Full Text]
|
|
|
|
|
|
D. M Mitchell and A. Woodcock Introduction Thorax, August 1, 1999; 54(90002): S1 - 1. [PDF]
|
|
|
|
 |
|
 L. M. Teran, M. Mochizuki, J. Bartels, E. L. Valencia, T. Nakajima, K. Hirai, and J.-M. Schröder Th1- and Th2-Type Cytokines Regulate the Expression and Production of Eotaxin and RANTES by Human Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 777 - 786. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Hogaboam, C. S. Gallinat, C. Bone-Larson, S. W. Chensue, N. W. Lukacs, R. M. Strieter, and S. L. Kunkel Collagen Deposition in a Non-Fibrotic Lung Granuloma Model after Nitric Oxide Inhibition Am. J. Pathol., December 1, 1998; 153(6): 1861 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wells Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis Thorax, December 1, 1998; 53(12): 1080 - 1087. [Full Text]
|
|
|
|
|
|
N. Dobashi, J. Fujita, Y. Ohtsuki, I. Yamadori, T. Yoshinouchi, T. Kamei, M. Tokuda, S. Hojo, H. Okada, and J. Takahara Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders Thorax, November 1, 1998; 53(11): 969 - 974. [Abstract] [Full Text]
|
|
|
|
|
|
A. U. WELLS, D. M. HANSELL, P. L. HASLAM, M. B. RUBENS, J. CAILES, C. M. BLACK, and R. M. du BOIS Bronchoalveolar Lavage Cellularity . Lone Cryptogenic Fibrosing Alveolitis Compared with the Fibrosing Alveolitis of Systemic Sclerosis Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1474 - 1482. [Abstract] [Full Text]
|
|
|
|
|
|
B. T. SOCIETY and S. O. C. COMMITTEE The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults---British Thoracic Society recommendations Thorax, April 1, 1990; 54(90001): 1S - 28. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
